https://www.inspiredhygiene.com/feed&follow=1
-
Opinion: What’s next for digital mental health companies?
Digital mental health start-ups may be looking like big tech companies — consider the $5.1 billion in venture capital investment in 2021...
-
Opinion: Race alone should not be used to allocate scarce Covid-19 treatments
In hospitals and health care systems, life and death decisions are being made about who should get scarce antiviral medications from Pfizer and...
-
Omicron’s sister variant spreads faster. So why did the one we call Omicron hit first?
Two years into a pandemic that turned us all into amateur virologists, we’ve learned that the best-spreading coronavirus variant will...
-
Experts question unusual authorization plan for Covid vaccine for kids under 5
The Food and Drug Administration’s willingness to consider authorizing a Covid-19 vaccine developed by Pfizer and BioNTech for children...
-
Despite Biden’s big promises and a far better understanding of the virus, Covid-19 is still raging through the nation’s prisons
WASHINGTON — On his first full day in office, President Biden promised to order the federal Bureau of Prisons to reevaluate its Covid-19...
-
Could Pap smears one day help detect breast and ovarian cancers?
Routine screenings have become a powerful tool in catching cervical cancer as early as possible. Now, research suggests the cervical cells...
-
STAT+: Native American tribes reach $590 million deal with J&J and three wholesalers over the opioid crisis
Three of the largest pharmaceutical wholesalers and a major drugmaker have reached a $590 million deal to settle lawsuits filed by hundreds of...
-
STAT+: Cardinal Health to pay $13 million to settle charges of paying kickbacks to doctors
Cardinal Health ( CAH ), one of the largest pharmaceutical wholesalers, agreed to pay $13.1 million to settle allegations of paying kickbacks to...
-
STAT+: Pfizer names new top development executive as Covid remakes the company
Pfizer has a lot going on these days: It’s developing Omicron booster shots , plans to test its Covid pill, Paxlovid, in children younger...
-
Oscar Health could get a boost with new funding and a spike in ACA enrollments
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this...
-
STAT+: Pharmalittle: More Democratic senators uncertain on Califf for FDA job; Moderna wins full approval for its Covid shot
Top of the morning to you, and a fine one it is. Clear blue skies and a crisp breeze are wafting about the Pharmalot campus, where a decided quiet...
-
More Democrats flag ‘questions,’ remain uncertain about Biden’s FDA pick, Robert Califf
WASHINGTON — Nearly a dozen Democratic senators aren’t yet willing to publicly support President Biden’s Food and Drug...
-
Opinion: The Karikó problem: Lessons for funding basic research
New scientific institutes are springing up all over the place these days: Arcadia Science , New Science , Arc Institute , Activate ,...
-
STAT+: He founded what became IBM’s most valuable health database. Now, he’s sounding an alarm about patient privacy
Ernie Ludy doesn’t normally give interviews. He cashed out of the pioneering medical data business he founded more than three decades ago...
-
How a decades-old database became a hugely profitable dossier on the health of 270 million Americans
To most Americans, the name MarketScan means nothing. But most Americans mean everything to MarketScan. As a repository of sensitive patient...
-
STAT+: Will the Biden administration approach march-in rights like Trump? Fight over pricey cancer drug offers a test
Next month, the National Institutes of Health is expected to decide whether to proceed with a request to widen access to a pricey cancer treatment...
-
Moderna wins full approval for its Covid-19 vaccine, as Novavax seeks authorization for its version
The ever-evolving landscape of Covid-19 vaccines shifted again on Monday, with Moderna winning full approval for its jab from the Food and Drug...
-
STAT+: In the heart of the booming biotech industry, workers are in short supply
It’s almost like Massachusetts has too many biotechs. The industry is hotter than ever, with companies routinely raising millions of...
-
STAT+: Pharmalittle: Chinese authorities summon AstraZeneca execs over insurance fraud; Lilly to invest $1.5B in two factories
Good morning, everyone, and welcome to another working week. We hope the weekend respite was somehow invigorating and relaxing, despite the storm...
-
STAT+: Madrigal drug for fatty liver disease clears safety hurdle in first of two late-stage studies
Madrigal Pharmaceuticals said Monday that its experimental pill significantly reduced liver fat by just under half without any serious safety...
-
Opinion: The hospital of the future won’t be what you expect
Close your eyes for a few seconds and imagine what a hospital will look like 10 years in the future. If medical robots, artificial intelligence,...
-
Opinion: A devil’s choice: Take an immune-suppressing drug and risk getting Covid or watch my wrist joints disintegrate?
Harebrained. That’s the best word to describe my starting to take an immunosuppressing drug like Humira in the midst of a pandemic where...
-
STAT+: Illumina’s embrace of long-read technology signals a shift in the DNA-sequencing market
SAN DIEGO — If DNA is the book of life, there’s a subplot around the race to read genetic information quickly, accurately, and...
-
Roche looks to compete against a blockbuster with its newly approved vision drug
Roche announced Friday that it received Food and Drug Administration approval for the first-ever bispecific antibody treatment for two common...
-
Early data indicate vaccines still protect against Omicron’s sister variant, BA.2
New data show that vaccines still protect against a spinoff of the Omicron variant, a welcome sign as the world keeps a close eye on the latest...